Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol

被引:67
作者
Amblard, Franck
Govindarajan, Baskaran
Lefkove, Benjamin
Rapp, Kimberly L.
Detorio, Mervi
Arbiser, Jack L.
Schinazi, Raymond F. [1 ]
机构
[1] Vet Affairs Med Ctr, Atlanta, GA 30333 USA
[2] Emory Univ, Dept Pediat & Dermatol, Atlanta, GA 30322 USA
关键词
antiviral; anti-tumoral; honokiol; magnolol; neolignans; RIE-1; EPITHELIAL-CELLS; NATURAL-PRODUCT; IN-VIVO; OFFICINALIS; GROWTH; AGENTS; ANGIOSARCOMA; APOPTOSIS; MICE;
D O I
10.1016/j.bmcl.2007.06.024
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of new bisphenol derivatives bearing allylic moieties were synthesized as potential analogs of honokiol and/or magnolol. Certain compounds exhibited specific anti-proliferation activity against SVR cells and moderate anti-HIV-1 activity in primary human lymphocytes. Compound 5h was the most potent compound and its anti-tumor activity was evaluated in vivo. Published by Elsevier Ltd.
引用
收藏
页码:4428 / 4431
页数:4
相关论文
共 19 条
[1]   Facile purification of honokiol and its antiviral and cytotoxic properties [J].
Amblard, Franck ;
Delinsky, David ;
Arbiser, Jack L. ;
Schinazi, Raymond F. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (11) :3426-3427
[2]   The antiangiogenic agents TNP-470 and 2-methoxyestradiol inhibit the growth of angiosarcoma in mice [J].
Arbiser, JL ;
Panigrathy, D ;
Klauber, N ;
Rupnick, M ;
Flynn, E ;
Udagawa, T ;
D'Amato, RJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (06) :925-929
[3]   Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo [J].
Bai, XH ;
Cerimele, F ;
Ushio-Fukai, M ;
Waqas, M ;
Campbell, PM ;
Govindarajan, B ;
Der, CJ ;
Battle, T ;
Frank, DA ;
Ye, KQ ;
Murad, E ;
Dubiel, W ;
Soff, G ;
Arbiser, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) :35501-35507
[4]   The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells [J].
Battle, TE ;
Arbiser, J ;
Frank, DA .
BLOOD, 2005, 106 (02) :690-697
[5]   Claisen rearrangement over the past nine decades [J].
Castro, AMM .
CHEMICAL REVIEWS, 2004, 104 (06) :2939-3002
[6]   Efficient synthesis and structure-activity relationship of honokiol, a neurotrophic biphenyl-type neolignan [J].
Esumi, T ;
Makado, G ;
Zhai, HF ;
Shimizu, Y ;
Mitsumoto, Y ;
Fukuyama, Y .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (10) :2621-2625
[7]   Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis [J].
Ishitsuka, K ;
Hideshima, T ;
Hamasaki, M ;
Raje, N ;
Kumar, S ;
Hideshima, H ;
Shiraishi, N ;
Yasui, H ;
Roccaro, AM ;
Richardson, P ;
Podar, K ;
Le Gouill, S ;
Chauhan, D ;
Tamura, K ;
Arbiser, J ;
Anderson, KC .
BLOOD, 2005, 106 (05) :1794-1800
[8]   Cytotoxic neolignans: an SAR study [J].
Kong, ZL ;
Tzeng, SC ;
Liu, YC .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (01) :163-166
[9]   Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells [J].
LaMontagne, KR ;
Moses, MA ;
Wiederschain, D ;
Mahajan, S ;
Holden, J ;
Ghazizadeh, H ;
Frank, DA ;
Arbiser, JL .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (06) :1937-1945
[10]  
LO YC, 1994, BIOCHEM PHARMACOL, V47, P549, DOI 10.1016/0006-2952(94)90187-2